TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Polypeptide Laboratories Holding (PPL) AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,164,553
|
885,421
|
648,729 |
| Financial expenses |
84,262
|
29,118
|
12,597 |
| Earnings before taxes |
-223,072
|
-141,497
|
-34,002 |
| EBITDA |
-383,563
|
-112,097
|
-13,185 |
| Total assets |
2,945,595
|
2,000,653
|
1,472,730 |
| Current assets |
1,005,143
|
388,015
|
311,385 |
| Current liabilities |
879,450
|
567,972
|
603,927 |
| Equity capital |
278,299
|
365,994
|
363,401 |
| - share capital |
134
|
134
|
135 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
9.4%
|
18.3%
|
24.7% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-19.2%
|
-16.0%
|
-5.2% |
| Return on assets (ROA) |
-4.7%
|
-5.6%
|
-1.5% |
| Current ratio |
114.3%
|
68.3%
|
51.6% |
| Return on equity (ROE) |
-80.2%
|
-38.7%
|
-9.4% |
| Change turnover |
274,572
|
289,239
|
133,008 |
| Change turnover % |
31%
|
49%
|
26% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.